CureMed Pharmacy is now offering Monoclonal Antibody (Outpatient) Infusion Therapy for COVID patients meeting criteria. This therapy is being offered during Pharmacy hours.
Referral can be made for any patient who is considered higher risk by criteria listed below or by consideration of benefit-risk for an individual patient by the referring healthcare provider. The patient must also have a positive COVID-19 test result within the past 24-48 hours.
Higher risk is defined as patients who meet at least one of the following criteria:
Are ≥ 65 years of age Have a body mass index (BMI) ≥ 25 Have chronic kidney disease Have diabetes Have immunosuppressive disease Are currently receiving immunosuppressive treatment Pregnancy HTN or Cardiovascular disease (including congenital heart disease) Chronic lung disease (for example, COPD, asthma [moderate to severe]. Interstitial lung disease, cystic fibrosis and pulmonary hypertension) Sickle Cell disease